Endo Tools Therapeutics (ETT), a company developing and marketing advanced endoscopic medical devices, and Fujifilm Middle East FZE, a subsidiary of FUJIFILM Holdings Corporation, today announce their strategic partnership, to enable patients living with obesity in the Middle East and Africa to access a novel endoscopic treatment through ETT’s endomina® platform.
07.08.2025 - 17:59:17Endo Tools Therapeutics and Fujifilm Middle East FZE Partner to Extend Access to Innovative Treatments for Obesity
and GIE in 2024. Moreover, endomina is included in the joint ASGE-ESGE guideline on primary endoscopic bariatric and metabolic therapies.
To date, over 1,200 gastroplasty procedures have been performed using Endo Tools Therapeutics’ devices across Europe, the US and the Middle East.
In Europe the devices are approved for use in endoscopic gastroplasty procedures for the treatment of obesity, while in the US they are cleared for placement of sutures and approximation of soft tissue in the gastrointestinal tract.
www.endotools.com
To date, over 1,200 gastroplasty procedures have been performed using Endo Tools Therapeutics’ devices across Europe, the US and the Middle East.
In Europe the devices are approved for use in endoscopic gastroplasty procedures for the treatment of obesity, while in the US they are cleared for placement of sutures and approximation of soft tissue in the gastrointestinal tract.
www.endotools.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20250630084663/en/
